about
HET0016, a selective inhibitor of 20-HETE synthesis, decreases pro-angiogenic factors and inhibits growth of triple negative breast cancer in miceThe prognostic significance of Wnt-5a expression in primary breast cancer is extended to premenopausal women.Certification of breast centres in Germany: proof of concept for a prototypical example of quality assurance in multidisciplinary cancer care.Opportunities for PET to deliver clinical benefit in cancer: breast cancer as a paradigmDC-SCRIPT: AR and VDR regulator lost upon transformation of prostate epithelial cells.
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Management of breast cancer--part I.
@ast
Management of breast cancer--part I.
@en
type
label
Management of breast cancer--part I.
@ast
Management of breast cancer--part I.
@en
prefLabel
Management of breast cancer--part I.
@ast
Management of breast cancer--part I.
@en
P2860
P356
P1433
P1476
Management of breast cancer--part I.
@en
P2093
Alison L Jones
Nicholas C Turner
P2860
P356
10.1136/BMJ.A421
P407
P577
2008-07-04T00:00:00Z